Covaxin
Photo: Republic World

COVID-19: COVAXIN BOOSTER DOSE ASSURES LONG-TERM IMMUNITY AGAINST NEW VARIANTS, SAYS STUDY

Bharat Biotech International Limited (BBIL), the manufacturer of India's indigenous vaccine Covaxin (BBV152), has stated that in a recent study it has been proven that the Covaxin booster dose has shown persistence of Immunity against emerging variants of COVID-19. The study conducted by the Indian… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply